Navigation Links
GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling
Date:3/26/2009

Leading Sucralose manufacturer Guangdong Food Industry Institute/L&P Food Ingredient Co. Ltd. (GDFII/L&P) today announced that the U.S. International Trade Commission (ITC) in Washington D.C. has extended the target date of its final decision in the sucralose case, from March 25 to April 3. This Section 337 patent dispute (docket# 337-TA-604) was filed against the company by its main competitor, Tate & Lyle Corporation (T&L)

Exeter, California (PRWEB) March 26, 2009 -- Leading Sucralose manufacturer Guangdong Food Industry Institute/L&P Food Ingredient Co. Ltd. (GDFII/L&P) today announced that the U.S. International Trade Commission (ITC) in Washington D.C. has extended the target date of its final decision in the sucralose case, from March 25 to April 3. This Section 337 patent dispute (docket# 337-TA-604) was filed against the company by its main competitor, Tate & Lyle Corporation (T&L).

"GDFII/L&P was the first company to manufacture sucralose outside of the U.S.A and continues to be committed to meeting its customer needs of high capacity and superior grade sucralose in the growing sucralose market in the United States and elsewhere, and remains confident of a positive outcome once the ITC issues its final determination," notes Mr. Sanyong Wang, a corporate officer of GDFII/L&P.

Mr. Bassam Faress, spokesperson of GDFII/L&P and Director of Sales/Marketing at Ingredients Specialties, Inc., a global alliance partner of GDFII/L&P, adds "we continue to look forward to this anticipated positive final ruling as we move ahead with our strategic marketing and expansion plans for Sucralose."

The U.S. ITC governs investigations into allegations of unfair trade practices and had in its September 2008 initial determination issued by Administrative Law Judge Charles E. Bullock of the ITC, noted that GDFI
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Mylan Confirms Four First-to-File Challenges
2. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
3. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
4. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
5. Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
6. Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol
7. ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
8. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
9. ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference
10. Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg
11. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling
GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling
(Date:12/2/2009)...EBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed that the U.S. Food and Drug Administration (FDA...ny,s PI3K/Akt pathway inhibitor compound, perifosi...ctory multiple myeloma. Keryx Biopharmaceuticals, ...
(Date:12/1/2009)...LINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/ ...y announced revenue guidance for the fourth quarte...lion, as compared with $69 million for the fourth ...esults was the first of two installment payments o...urth quarter 2008 results was a one-time $1.8 mill...
(Date:12/1/2009)..., CAMBRIDGE, Mass., Dec. 1 To a...stry and to promote its potential, a group of indi...he Synthetic Biology Industry Association (SynBIA)...f the association is to provide a forum for indivi...industry, address its opportunities and its challe...
(Date:12/1/2009)...N FRANCISCO, Dec. 1 The Burrill Bi...f the value it lost in October. The Select,s gain ... month for the general markets with the Dow up 6.5...he gains held firm in the final two trading days o...h Thanksgiving holiday shopping and Dubai,s report...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...d in Indonesia, Thailand and Sri Lanka when the ch...lled the wealthier nations of the world stingy for...d off the remark as yet another reason to dislike ...have done, anyway: They opened their hearts and wa...able outpouring of private and corporate relief f...
...VoIP, may have found the missing link that would e...e a lot of telephone companies go into a state of ...paralyzed. , ,The telcos and cable companies are b...sue of delivering voice over the Internet and to b...evices. This enables them to provide the end-user ...
...ve Ophir Creek in Alaska. Credit: Alaska Division ... rural Alaskan knowledge can now spread globally t...nmental Remote Sensing Center and the Alaska Divis...MapTeach effort, or Mapping Technology Experience...combine geospatial information with traditional kn...
Other Biology Technology:Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3The day the old telephony died 2The day the old telephony died 3MapTeach project spreads Alaskan geographic knowledge online 2MapTeach project spreads Alaskan geographic knowledge online 3
(Date:12/2/2009)...s of carbon about a nanometer in diameterhave been...ultrastrong fibers, electrical wires in molecular ...ells. Thanks to a new development by researchers a...gy (NIST) and five partners, you can add one more ... of an aggressive form of breast cancer. , HER2 ...
(Date:12/2/2009)...cording to the National Institute of Health, 40 pe...abetes already have some stage of diabetic retinop...caused by leaky blood vessels, is a major cause of...he most feared diabetic complications. In fact, u...s for 10 years or more will experience some form o...
(Date:12/1/2009)...Dec. 1 GestureTek Inc. today annou...ey, portable, plug and play interactive projection...inment and touring promotions. GestureTek is the i...enabled gesture recognition technology for interac...ms. ,, Guaranteed for quality, the CUBE has TUV...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 1Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 2Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation 56873 3Regeneron Announces September 2009 Investment Conference Presentations 56871 1Regeneron Announces September 2009 Investment Conference Presentations 56871 2BayCare Outpatient Center Opens in Westchase Florida 56869 1
...researchers have used an experimental therapy in m...in a leading cause of inherited blindness. , The t...Research, involves injecting the eye with a bit of...lps disable the gene. , Normally the gene is es... of it are passed from generation to generation in...
...out of Africa some 60,000 years ago to populate th...he bacterium Helicobacter pylori, which causes gas... bacterium spread throughout the entire world. Thi...am of scientists led by Mark Achtman from the Max ...Germany. The researchers also discovered that diff...
... but they keep growing because they don,t react to...ers at Washington University School of Medicine in...ssenger into cancer cells that forces them to resp... the most sinister pathogens around ?HIV. , "HIV k...s of cells," says senior author William G. Hawkins...
Other Biology News:Gene therapy for blindness clears hurdle in mice 2Out of Africa -- Bacteria, as well 2HIV protein enlisted to help kill cancer cells 2HIV protein enlisted to help kill cancer cells 3
GIBCO Schneider's Drosophila Medium (1X) liquid from Invitrogen
Virology LabFax from Promega
GIBCO IPL-41 Insect Medium (1X) liquid from Invitrogen
GIBCO Newborn Calf Serum from Invitrogen
Biology Products: